Correlation Between Amylyx Pharmaceuticals and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Structure Therapeutics American, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Structure Therapeutics.
Diversification Opportunities for Amylyx Pharmaceuticals and Structure Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Amylyx and Structure is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and Structure Therapeutics
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 1.45 times more return on investment than Structure Therapeutics. However, Amylyx Pharmaceuticals is 1.45 times more volatile than Structure Therapeutics American. It trades about 0.08 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.23 per unit of risk. If you would invest 496.00 in Amylyx Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 37.50 from holding Amylyx Pharmaceuticals or generate 7.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amylyx Pharmaceuticals vs. Structure Therapeutics America
Performance |
| Timeline |
| Amylyx Pharmaceuticals |
| Structure Therapeutics |
Amylyx Pharmaceuticals and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amylyx Pharmaceuticals and Structure Therapeutics
The main advantage of trading using opposite Amylyx Pharmaceuticals and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |